MetLife Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,329
Closed -$835K 2956
2025
Q1
$835K Sell
6,329
-14
-0.2% -$1.85K ﹤0.01% 1452
2024
Q4
$530K Sell
6,343
-145
-2% -$12.1K ﹤0.01% 1766
2024
Q3
$475K Sell
6,488
-127
-2% -$9.29K ﹤0.01% 1814
2024
Q2
$453K Sell
6,615
-41,388
-86% -$2.83M ﹤0.01% 1774
2024
Q1
$3.32M Sell
48,003
-1,367
-3% -$94.6K 0.02% 724
2023
Q4
$3.54M Hold
49,370
0.03% 679
2023
Q3
$2.57M Hold
49,370
0.02% 786
2023
Q2
$3.13M Buy
49,370
+1,499
+3% +$94.9K 0.02% 727
2023
Q1
$2.59M Sell
47,871
-846
-2% -$45.8K 0.02% 815
2022
Q4
$2.58M Hold
48,717
0.02% 789
2022
Q3
$2.27M Buy
48,717
+1,135
+2% +$52.8K 0.02% 825
2022
Q2
$2.72M Buy
47,582
+5,067
+12% +$289K 0.02% 772
2022
Q1
$2.6M Buy
42,515
+18,160
+75% +$1.11M 0.02% 884
2021
Q4
$1.27M Sell
24,355
-2,111
-8% -$110K 0.01% 1031
2021
Q3
$987K Hold
26,466
0.01% 1122
2021
Q2
$1.08M Hold
26,466
0.01% 1119
2021
Q1
$898K Hold
26,466
0.01% 1208
2020
Q4
$842K Hold
26,466
0.01% 1211
2020
Q3
$679K Hold
26,466
0.01% 1220
2020
Q2
$679K Buy
26,466
+3,201
+14% +$82.2K 0.01% 1213
2020
Q1
$358K Buy
23,265
+3,659
+19% +$56.2K ﹤0.01% 1392
2019
Q4
$673K Hold
19,606
0.01% 1294
2019
Q3
$146K Hold
19,606
﹤0.01% 2117
2019
Q2
$254K Hold
19,606
﹤0.01% 1889
2019
Q1
$239K Hold
19,606
﹤0.01% 1885
2018
Q4
$223K Hold
19,606
﹤0.01% 1846
2018
Q3
$425K Hold
19,606
﹤0.01% 1632
2018
Q2
$346K Hold
19,606
﹤0.01% 1631
2018
Q1
$413K Buy
19,606
+2,613
+15% +$55K ﹤0.01% 1479
2017
Q4
$246K Buy
+16,993
New +$246K ﹤0.01% 1822